GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Healthcare AI Acquisition Corp (NAS:HAIA) » Definitions » Shares Outstanding (EOP)

Healthcare AI Acquisition (Healthcare AI Acquisition) Shares Outstanding (EOP) : 5.98 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Healthcare AI Acquisition Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Healthcare AI Acquisition's shares outstanding for the quarter that ended in Dec. 2023 was 5.98 Mil.

Healthcare AI Acquisition's quarterly shares outstanding stayed the same from Sep. 2023 (5.98 Mil) to Dec. 2023 (5.98 Mil).

Healthcare AI Acquisition's annual shares outstanding declined from Dec. 2022 (26.95 Mil) to Dec. 2023 (5.98 Mil). It means Healthcare AI Acquisition bought back shares from Dec. 2022 to Dec. 2023 .


Healthcare AI Acquisition Shares Outstanding (EOP) Historical Data

The historical data trend for Healthcare AI Acquisition's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthcare AI Acquisition Shares Outstanding (EOP) Chart

Healthcare AI Acquisition Annual Data
Trend Dec21 Dec22 Dec23
Shares Outstanding (EOP)
27.31 26.95 5.98

Healthcare AI Acquisition Quarterly Data
Feb21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.95 26.95 7.13 5.98 5.98

Competitive Comparison of Healthcare AI Acquisition's Shares Outstanding (EOP)

For the Shell Companies subindustry, Healthcare AI Acquisition's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healthcare AI Acquisition's Shares Outstanding (EOP) Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Healthcare AI Acquisition's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Healthcare AI Acquisition's Shares Outstanding (EOP) falls into.



Healthcare AI Acquisition Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Healthcare AI Acquisition  (NAS:HAIA) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Healthcare AI Acquisition Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Healthcare AI Acquisition's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Healthcare AI Acquisition (Healthcare AI Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
190 Elgin Avenue, George Town, Grand Cayman, CYM, KY1-9008
Website
Healthcare AI Acquisition Corp is a blank check company.
Executives
Polar Asset Management Partners Inc. 10 percent owner 16 YORK STREET SUITE 2900, TORONTO A6 M5J 0E6
Atticus Ale, Llc 10 percent owner 8 THE GREEN, SUITE 15614, DOVER DE 19901
Zikang Wu director, 10 percent owner, officer: Chief Executive Officer PO BOX 309, UGLAND HOUSE, GRAND CAYMAN E9 KY1-1104
Yuerong Tang director 8 THE GREEN, SUITE 15614, DOVER DE 19901
Hao Tian director 8 THE GREEN, SUITE 15614, DOVER DE 19901
Zixun Jin director 8 THE GREEN, SUITE 15614, DOVER DE 19901
Weiyi Zheng director 8 THE GREEN, SUITE 15614, DOVER DE 19901
Robert Piconi director C/O HEALTHCARE AI ACQUISITION, 7 STANLEY GARDENS, LONDON X0 W112ND
Elizabeth K Weymouth director 55 HUDSON YARDS, 44TH FLOOR, NEW YORK NY 10001
Xavier Flinois director
James William Brooks director 7 STANLEY GARDENS, LONDON X0 W112ND
Patrick Hargutt director, officer: Chief Financial Officer 7 STANLEY GARDENS, LONDON X0 W112ND
Simon Lyall-cottle director, officer: Chief Executive Officer 7 STANLEY GARDENS, LONDON X0 W112ND
Healthcare Ai Acquisition Llc 10 percent owner 7 STANLEY GARDENS, LONDON X0 W112ND
Greg Caswill director C/O HEALTHCARE AI ACQUISITION, 7 STANLEY GARDENS, LONDON X0 W112ND